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Abstract: Ultrasonography allows the quantification of dermal density and echogenicity 
changes during the physiological senescence process. Some active ingredients are able to slow 
down the tissular degeneration and disorganization process. The purpose of this study was to 
assess the cutaneous changes induced by the topical use of products containing Viniferol® as 
active ingredient, using high-frequency ultrasound. The study was performed over 12 weeks 
and included 80 healthy Caucasian female subjects, aged 22–75 years, divided into two groups: 
the study group and the control group. The product was applied according to a predetermined 
protocol. The measurements performed for each subject were: the thickness of the epidermis 
and dermis (mm), the number of low, medium, and high echogenic pixels, and the number of 
low echogenic pixels in the upper dermis/number of low echogenic pixels in the lower dermis. 
All the parameters showed a significant improvement. Ultrasound measurements showed an 
increase of the mean thickness of the epidermis (P , 0.0001) and dermis (P , 0.0001) follow-
ing the application of the Viniferol product as compared to the control group. The changes in 
the dermal echogenicity confirm the efficacy and direct action of Viniferol upon the cutaneous 
fibroblasts. No side effects related to the treatment were recorded. The study proves the efficacy 
of this active ingredient in the cutaneous senescence process as well, as the fact that anti-aging 
prophylaxis should be initiated in the 20–40 year critical age group. This interval involves spe-
cific changes in dermal echogenicity that quantify intense molecular, biochemical and structural 
changes, being thus mostly and highly responsive to the anti-aging therapy.
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Introduction
High-frequency ultrasound is a noninvasive diagnostic method with several applications 
in the field of internal medicine and, recently, clinical dermatology as well as dermato-
oncology and dermatocosmetics.1,2 It can represent a “noninvasive histological tool” for 
the quantification of the cutaneous structure or of the cutaneous pathology by monitoring 
the evolution of cutaneous lesions and the assessment of topical therapies’ efficacy in 
chronic inflammatory disorders (morphea, scleroderma, psoriasis), for the quantifica-
tion of the intrinsic and extrinsic senescence process, as well as the efficacy of topical 
or generally applied therapies.3 It can also be used as an important research tool of the 
cutaneous senescence process and the efficacy of various anti-aging therapies.4,5
The use of high-frequency ultrasound in the assessment of the regenerative effects 
of various anti-aging therapies is an exciting and important area for research. From 
all the available imaging methods, high-frequency ultrasound (Dermascan 20 MHz 
Cortex   Technology) is a new study tool focused on the assessment of the cutaneous Clinical, Cosmetic and Investigational Dermatology 2012:5 submit your manuscript | www.dovepress.com
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physiological and pathological features, having a penetration 
depth of up to 2.5 cm.
Collagen is an echogenic marker protein, synthesized by 
dermal fibroblasts, which can be identified by high-frequency 
ultrasound. The changes of the extracellular matrix, consist-
ing in variations of the dermal density and echogenicity 
throughout the physiological senescence process, or during 
several anti-aging therapies quantify subtle reactions at 
molecular, cellular, and tissular level that influence the local 
homeostasis.6
High-frequency ultrasound allows an objective assess-
ment of the cutaneous structure: the thickness of the epi-
dermis and dermis as well as the dermal density, which are 
useful parameters for the quantification of the cutaneous 
regeneration process.7,8 Several changes of the cutaneous 
structure after topical prednisone therapy in children, or 
anti-aging natural supplement therapies in adults were ultra-
sonographically successfully assessed.9
Previous studies have shown that the thickness of the epi-
dermis and dermis, as well as the dermal density are important 
parameters that assess the cutaneous regeneration process.
The neosynthesis of the protein structures induces an 
increase of the dermal echogenicity and density, local cell 
architecture changes, and an increase of the dermis and 
epidermis thickness. The epidermis is the morphological 
expression of the changes in the subjacent dermis.7
It has been proved that certain ultrasonographic markers, 
such as SLEB (subepidermal low echogenity band) or the 
LEPs/LEPi ratio (number of low echogenic pixels in the upper 
dermis/number of low echogenic pixels in the lower dermis) 
can quantify the cutaneous senescence process, as well as the 
efficacy of various anti-aging therapies.2,10,11
As far as the anti-aging therapy is concerned, Vinif-
erol, a standardized extract from Bordeaux vine stalks, 
is one of the newest and very efficient anti-wrinkle and 
anti-aging agents. The active ingredient of Viniferol is 
ε-viniferine, a generic name for a new class of phytoalex-
ins characterized as resveratrol dimers. Besides the well-
known antioxidant effect of this flavonoide-containing 
extract, it has a direct action on the protein expression 
genes involved in the proliferation and differentiation of 
integumentary cells. These are retinoid-like effects which 
decrease cellular differentiation and increase cellular 
growth. Due to this action, Viniferol profoundly restruc-
tures and regenerates the skin and due to its antioxidant 
properties, it reestablishes the metabolic balance of the 
cutaneous cells, slowing down the tissular degeneration 
and disorganization process.12
Even though the general anti-aging effects of the fla-
vonoids are well known, until now no scientific studies 
investigated the action of Viniferol at the cutaneous level by 
using high-frequency ultrasound.
The purpose of the study is the assessment, with the 
help of high-frequency ultrasound, of the cutaneous changes 
induced by topical use of products containing Viniferol.
Materials and methods
Patients
Eighty female subjects, aged 22–75 years, who requested 
prophylaxis and anti-aging therapy with flavonoids, were 
prospectively included in the study. Half (50%) of the sub-
jects belonged to Fitzpatrick phototype class II and 50% to 
phototype class III.13 The study excluded patients with known 
allergies to topical flavonoids, cutaneous facial lesions, resur-
facing or other anti-aging therapies in the last 2 months, or 
those who used phototherapy or oral contraception.
The subjects taken into the study were divided into two 
categories: a study group and a control group. The study group 
followed the proposed anti-aging therapy for 12 weeks, accord-
ing to a standard protocol. In the morning, a hydrating emollient 
cream, based on occlusive hydrating agents was applied at the 
facial level (including the zygomatic area) by lightly massaging 
the area for 2 minutes.14 In the evening, an anti-aging product 
containing Viniferol, was applied in the same manner. No other 
cosmetic products were used by the subjects during the 12 weeks 
of study. The control group followed a placebo therapy for 12 
weeks, using only moisturizing cream in the morning and eve-
ning, applied at the facial level, including the zygomatic area.
For every subject, ultrasonographic images were taken 
from the zygomatic level at the beginning and 12 weeks after 
the local application of the emollient, hydrating product, and 
the anti-aging, Viniferol-based cream.
The study was approved by the Ethical Committee of 
University of Medicine and Pharmacy Iuliu Hatieganu, 
Cluj-Napoca, Romania. Every subject was informed about 
the nature and purpose of the study, and signed a written 
consent before enrolling into the study.
Ultrasonographic evaluation
The ultrasonographic evaluation was performed with the 
Dermascan equipment (Cortex Technologies, Hadsund, 
Denmark), containing a 20 MHz transducer, that allows the 
“in vivo” acquirement of sectional cutaneous images up to 
a depth of 2.5 cm.
Dermascan consists of three major components: a trans-
ducer, an elaboration system, and a database (Figure 1).Clinical, Cosmetic and Investigational Dermatology 2012:5 submit your manuscript | www.dovepress.com
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The ultrasonic wave is partially reflected at the boundary 
between adjacent structures and generates echoes of different 
amplitudes. The intensity of the reflected echoes is evaluated by 
a microprocessor and visualized as a colored   two-dimensional 
image.1 The color scale of echogenicity is: white – yellow – red – 
green – blue – black. Normally, the epidermal   echogenicity 
appears as a white band, the dermis is expressed as a two-color 
composition: yellow and/or red, and the subcutaneous layer 
appears either green or black (Figure 2).
The transducer was applied on the integument, on the 
left zygomatic area, parallel to the zygomatic arcade, after 
previously having cleaned the cutaneous surface and applied 
ultrasonographic gel. The gain curve was adjusted at a value of 
20 dB, at a speed of ultrasound at tissue level of 1580 m/s.
The obtained images were further processed with image 
analysis software (Dermavision, Cortex Technology).
For every subject, the following parameters were mea-
sured on the images obtained before and after therapy: thick-
ness of the epidermis and dermis (mm), the number of LEP 
(low echogenic pixels), MEP (medium echogenic pixels), 
HEP (high echogenic pixels), LEPs/LEPi ratio.
The thickness of the epidermis was obtained by calculating 
the mean of three measurements performed at three differ-
ent sites of each image (the two extremities of the   analyzed 
image and the center of the image). The thickness of the 
dermis was obtained by measuring the distance between the 
dermo-epidermal and the dermo-hypodermic junction at the 
same three different sites and by establishing the mean of 
the three values.
The analysis software used has the pixel amplitude corre-
sponding to a numerical scale set between 0–255. By selecting 
a certain interval from the 0–255 scale, we obtained values 
corresponding to a certain pixel type, present in the analyzed 
image. Thus, the 0–30 interval corresponds to LEP, the 
50–150 interval to MEP, and the 200–255 interval to HEP.
The number of LEP were determined separately in the 
upper (LEPu) and lower (LEPl) dermis. The boundary 
between these regions was the line chosen as parallel to the 
epidermal entrance echo and dividing the dermal image into 
two parts of equal thickness. The ratio of LEP number in the 
upper and lower dermis (LEPs/LEPi) was calculated.
statistical analysis
Statistical analysis was performed with SPSS (v 15.0; 
SPSS Inc, Chicago, IL). The data we obtained were 
  analyzed,   calculating the mean and standard deviation for 
the   quantitative variables of every group and the propor-
tions for the qualitative variables. The difference of means 
before and after treatment was tested using a t-test for paired 
samples, and the relationship between different parameters 
was assessed through Spearman’s correlation coefficients. 
A P value ,0.05 was considered significant.
Results and discussion
Forty female subjects with a mean age of 49.60 ± 14.19 
years (range 22–75 years) were included in the study group. 
Twelve subjects (30%) were under the age of 40, 16 subjects 
Epidermis
Dermis
Hypodermis
Figure 2 Ultrasound image of the skin: epidermis, dermis, hypodermis.
Figure 1 Ultrasonographic equipment (Dermascan C, Cortex Technology).Clinical, Cosmetic and Investigational Dermatology 2012:5 submit your manuscript | www.dovepress.com
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(40%) between 40–60 years and twelve (30%) over the age 
of 60. The control group was composed of subjects aged 
22–75 years as well, divided into the above mentioned age 
categories.
All subjects involved in the study tolerated the therapy, 
without evoking adverse effects (erythema, pruritus, ocular 
disturbance). Subjectively, post-flavonoid therapy, a signifi-
cant hydration of the skin throughout the day and an increase 
of the cutaneous tonicity was noticed.
The thickness of the epidermis in the study group initially 
was 0.129 ± 0.237 mm, and the thickness of the dermis 
1.434 ± 0.241 mm.
After therapy, an increase of the mean thickness of the epi-
dermis (0.129 ± 0.237 mm vs 0.150 ± 0.323 mm, P , 0.000), 
and of the dermis (1.434 ± 0.241 mm vs 1.569 ± 0.219 mm, 
P , 0.0001) was observed (Tables 1 and 2).
The thickness of the dermis increased mainly in the 40–60 
years age group (1.413 ± 0.280 mm vs 1.569 ± 0.279 mm, 
P = 0.001), and less, but still significantly in the ,40 years 
group (1.416 ± 0.266 mm vs 1.585 ± 0.150 mm, P = 0.015), 
while in those .60 years, the increase was not statisti-
cally significant (1.480 ± 0.157 mm vs 1.554 ± 0.204 mm, 
P = 0.097).
At the same time, at the dermal level, the number of LEP 
decreased (15,153.53 ± 3589.86 vs 12,958.48 ± 3628.35, 
P , 0.0001), but this aspect was only noticed in the 
lower dermis (6949.75 ± 1966.93 vs 6257.62 ± 2224.88, 
P = 0.016), not in the upper dermis (7290.55 ± 1794.60 vs 
6940.65 ± 2150.30, P = 0.168).
Overall, the LEPs/LEPi ratio increased significantly 
after flavonoid therapy (1.092 ± 0.330 vs 1.259 ± 0.631, 
P = 0.011).
We also noticed an increase of MEP (3359.72 ± 1457.36 vs 
3983.47 ± 1401.24, P = 0.013) and HEP (460.27 ± 323.93 vs 
750.90 ± 493.82, P , 0.0001) after therapy.
The general variation pattern of the quantifiable ultra-
sonographic parameters after flavonoid therapy is illustrated 
in Table 1 and Figure 3.
If we consider the variation of the ultrasonographic 
parameters after topical flavonoid therapy according to the 
phototype class of the subjects, it can be noticed that after 
therapy, there is a significant increase of the LEPs/LEPi 
ratio in the subjects belonging to phototype class II, not III 
(Table 2).
In the placebo group, we noticed no significant thickening 
of the epidermis and a slight increase of the dermis after 
therapy (1.433 ± 0.34 mm vs 1.486 ± 0.14 mm). The 
number of LEP at dermal level also show a slight increase 
(13,213 ± 1284 vs 15,374 ± 2318, P = 0.1) due to an optimal 
hydration of the skin and a discrete decrease of high echogen-
ity pixels (421.8 ± 121.18 vs 368.3 ± 104.03, P = 0.07). The 
LEPs/LEPi ratio showed no particular display according to 
the age or phototype of the subjects.
The obtained results are in accordance with the data 
published in literature. Thus, locally applied flavonoids 
induce the neosynthesis of the fibrillary structures, but also 
of glycosaminoglycans, which display intense hydrophilic 
properties, favoring the cutaneous hydration.
It is well known that flavonoids have important anti-aging 
properties not only at a cutaneous level, but at the level of 
the entire organism. Viniferol, a molecule with proven anti-
aging and antioxidant properties, exhibits a complex action 
at the cutaneous level: it interacts with fibroblastic receptors, 
amplifies the interrelation fibrocyte-extracellular matrix, 
modulates the adhesiveness molecules and interferes with 
the oxidative stress process and nonenzymatic glycation, 
with a regenerative effect at cutaneous level.15
After therapy, a significant increase of the mean thickness 
of the epidermis and dermis was noticed, which once again 
confirms the presence of a complex, regenerative dermal 
process, induced by flavonoids.16,17
The dermal thickness increased the most in the 40–60 
years age group, to a lesser extent, but still significantly 
under the age of 40 years, and insignificantly over 60 years. 
We can affirm that topical flavonoid products have the best 
efficacy on mature integument, with specific structural and 
hormonal characteristics. In young subjects (,40 years) the 
thickness of the dermis increases discretely as the dermis is 
a young connective tissue, rich in glycosaminoglycans and 
thus, properly hydrated.18
After the age of 60, the extracellular matrix (fibrocytes, 
fibers, glycosaminoglycans) of the skin undergoes characteris-
tic degenerative changes. Therefore, the flavonoid-based anti-
Table  1  Cutaneous  parameters  quantified  by  high-frequency 
ultrasound before and after treatment
Before treatment After treatment P value
Thickness of  
epidermis (mm)
        0.13 ± 0.24         0.15 ± 0.32 ,0.0001
Thickness of  
dermis (mm)
        1.43 ± 0.24         1.57 ± 0.22 ,0.0001
LeP 15,153.53 ± 3589.86 12,958.48 ± 3628.35 ,0.0001
MeP   3359.72 ± 1457.36   3983.47 ± 1401.24 0.013
heP     460.27 ± 323.93     750.90 ± 493.82 ,0.0001
LePs   7290.55 ± 1794.60   6940.65 ± 2150.30 0.168
LePi   6949.75 ± 1966.93   6257.62 ± 2224.88 0.016
LePs/LePi         1.09 ± 0.33         1.26 ± 0.63 0.011Clinical, Cosmetic and Investigational Dermatology 2012:5 submit your manuscript | www.dovepress.com
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aging therapy has less effective regenerative changes in this age 
interval. These regenerative changes could be amplified though 
by the use of products able to interfere with the characteristic 
aging mechanisms for this specific age group.
At the same time, concomitantly with the change in dermal 
thickness, the number of LEP decreased in the lower dermis, 
but not in the upper dermis. The LEPs/LEPi ratio also increased 
significantly after therapy. The decrease in the number of LEP 
in the lower dermis is proportional to the significant increase 
of MEP and HEP that quantify protein neosynthesis, as well as 
cytoarchitectural reorganizations of the extracellular matrix.
According to the literature, the cutaneous imaging param-
eters that can be considered as objective in the evaluation of 
the cutaneous aging/regeneration process are the following:
•	 LEP quantifies the degree of cutaneous hydration, inflam-
matory processes, solar elastosis, collagen degeneration.
•	 MEP and HEP quantify the structures of collagen and 
elastin fibers and microfibrils.
•	 The LEPs/LEPi ratio allows an appreciation of the density 
and integrity of the extracellular matrix, both from the 
upper and lower dermis, which vary according to age, 
UV-ray exposure, and therapy.16
The data obtained from the study shows important ultra-
sonographic changes at the cutaneous level after anti-aging 
therapy. Flavonoids have a complex action at the dermal 
level, interfering with several mechanisms involved in the 
senescence process. They act at the level of fibrocytes, on 
specific receptors, turning inactive mature cells into young, 
metabolically active ones.19
Also, studies performed in order to assess the phyto-
oestrogen activity of Viniferol (evaluation of gene expression, 
coding for typical differentiation proteins) have shown that it 
influences gene expression and cell proliferation both at the 
epidermal and dermal levels. Therefore Viniferol decreases 
gene expression in Loricrine, Fillagrin, and Keratin 11, and 
increases gene expression in Calgranulin B.20
The synthesis of the protein structures is initiated at the 
intracellular level. The trophocollagen molecules, elastin, and 
the glycosaminoglycans are extracellularly assembled into micro-
fibrils, fibers, or proteoglycans. Depending on the biochemical 
structure, the level of organization, architectural orientation, 
and quantity, the proteins show a certain cutaneous echogenity 
degree. The low echogenity pixels that quantify the hydration 
degree of the extracellular matrix especially in the lower dermis, 
are replaced by medium and high echogenity pixels, quantifying 
protein synthesis. The MEP codify the presence of elastin and 
collagen microfibrils. Once these are assembled into mature 
fibers, the local echogenicity increases, and are expressed as 
hyperechogenic areas (HEP). The increase of the LEPs/LEPi ratio 
quantifies the replacement of the hypoechogenic pixels from the 
lower dermis with medium and high echogenic pixels as a result 
of protein   neosynthesis. Type I collagen, that is   predominant at 
the dermal level (  punctiform hyperechogenic pixels) is organized 
in fibers,   visible as hyperechogenic bands, having a parallel 
Table 2 Variation of the cutaneous parameters quantified by high-frequency ultrasound before and after treatment, according to phototype
Phototype III Phototype II
Before treatment After treatment P value Before treatment After treatment P value
epidermis (mm)   0.1288 ± 0.026     0.151 ± 0.027 ,0.0001   0.129 ± 0.021   0.148 ± 0.037 0.020
Dermis (mm)     1.441 ± 0.270     1.570 ± 0.263 0.001   1.427 ± 0.214   1.568 ± 0.172 0.003
LeP 15,059.25 ± 4063.97 13,864.75 ± 3824.33 0.015 15,247.8 ± 3162.14 12,052.2 ± 730.34 ,0.0001
MeP   3120.10 ± 1725.95   3850.95 ± 1487.32 0.046 3599.35 ± 1122.42   4116.0 ± 1334.62 0.151
heP   379.35 ± 280.94   645.50 ± 373.59 ,0.0001   541.20 ± 350.25   856.3 ± 581.03 0.004
LePs   7071.65 ± 1754.22   6961.1 ± 2236.66 0.725 7509.45 ± 1852.70 6920.20 ± 2118.53 0.148
LePi   7007.65 ± 2150.80   6737.15 ± 2205.91 0.480 6891.85 ± 1818.86 5778.10 ± 2193.29 0.010
LePs/LePi     1.035 ± 0.262     1.096 ± 0.300 0.200   1.1499 ± 0.384   1.4227 ± 0.820 0.026
Age
interval
<40
>60
41–60
Before therapy After therapy
Figure 3 Ultrasonographic skin aspect before and after topical therapy, on different 
age groups.Clinical, Cosmetic and Investigational Dermatology 2012:5 submit your manuscript | www.dovepress.com
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display in the lower dermis. These   hyperechogenic bands, visible 
especially on photoprotected sites, represent an ultrasonographic 
marker of the intrinsic aging process.21
The collagen–elastin protein structure, in different orga-
nization stages, is quantified by pixels of different amplitude. 
The post-therapeutic changes, visible on the sonograms as an 
increase of medium and high echogenic pixels, are suggestive 
of increased protein synthesis, the assembly of molecules to 
filaments, fibrils, and eventually, collagen fibers. According 
to our observations, there is a direct relationship between the 
genetically determined cutaneous phototype, the structure 
and repartition of echogenic proteins (collagen, elastin) and 
the different response to anti-aging therapies.22
If we consider the significant changes of the ultrasono-
graphic parameters after anti-aging therapy depending on the 
phototype of the subject, a significant increase of the LEPs/
LEPi ratio is present in the subjects in phototype II class, but 
not class III. This observation would justify the correlation of 
the anti-aging therapy with the cutaneous phototype. Further 
studies are necessary to confirm the different reactivity of 
the phototype classes to local therapies.
The synthesis process of fibrillary proteins depends on 
several factors, involving complex, targeted, and personal-
ized therapies. According to the “wear and tear” theory, 
throughout life, intrinsic and extrinsic mechanisms associated 
to the senescence process reduce the regenerative capacity 
of cells, leading to post-translational changes at the level of 
intracellular and extracellular proteins, such as oxidation and 
nonenzymatic glycation.
Flavonoids, through complex mechanisms, interfere 
with the reactions involved in the senescence process, and 
induce the synthesis of the extracellular matrix. According 
to our data, Viniferol-based products are more efficient 
in the 40–60 years age group, characterized by complex 
biological changes at the cutaneous level. Viniferol shows 
real and important anti-aging properties, since it interferes 
concomitantly with the genetic, oxidative, immunologic, and 
metabolic mechanisms that are involved in the cutaneous 
aging process.23
Prophylaxis of the aging process should start before the 
age of 40 years, preferably in the critical age group (20–40 
years), which is characterized by important changes at the 
tissular, cellular, and molecular levels.24 The optimization 
of anti-aging therapy, according to special studies, requires 
targeted, personalized therapies, adapted to the hormonal, 
genetic, oxidative, immunologic, and metabolic status of the 
subject, and is capable of interfering with deficient mecha-
nisms in certain age groups.
High-frequency ultrasound can be used as a modern, 
noninvasive, histological tool for the assessment of various 
anti-aging therapies, with applications in the fields of phar-
macology and dermato-cosmetology.
Conclusions
High-frequency ultrasound is a modern, noninvasive method 
that allows the assessment of the efficacy of anti-aging 
therapies. After topical flavonoid-based therapy, a significant 
increase of the epidermis and dermis was noticed, especially 
in the 40–60 years age group. Concomitantly, other cutane-
ous changes take place: decrease in the number of LEP and 
increase in the MEP and HEP. The cutaneous changes are 
more marked in subjects belonging to phototype class II. 
Anti-aging prophylaxis should be initiated in the 20–40 
years critical age group, involving personalized therapies 
also adapted to the phototype.
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